• Inmagene receives IND clearance for IMG-008, a long-acting IL-36R mAb

    1 month ago - By San Diego Biotechnology

    SAN DIEGO, SHANGHAI and SYDNEY, Feb. 6, 2023 /PRNewswire/ - Inmagene Biopharmaceuticals announced that the U.S. Food and Drug Administration recently granted the initial investigational new drug application for its drug candidate...
    Read more ...